 Stephanie Crowley
Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 35 | 2024 | 515 | 6.550 |
Why?
| | Sleep | 34 | 2025 | 885 | 5.400 |
Why?
| | Melatonin | 21 | 2023 | 163 | 3.900 |
Why?
| | Light | 13 | 2023 | 395 | 2.250 |
Why?
| | Sleep Disorders, Circadian Rhythm | 12 | 2021 | 52 | 2.100 |
Why?
| | Work Schedule Tolerance | 4 | 2018 | 52 | 1.400 |
Why?
| | Biological Clocks | 4 | 2018 | 46 | 1.350 |
Why?
| | Adolescent Behavior | 3 | 2025 | 538 | 1.190 |
Why?
| | Circadian Clocks | 4 | 2020 | 58 | 1.190 |
Why?
| | Wakefulness | 5 | 2017 | 172 | 1.150 |
Why?
| | Affect | 2 | 2025 | 316 | 1.110 |
Why?
| | Schools | 5 | 2022 | 453 | 1.000 |
Why?
| | Seasons | 6 | 2021 | 546 | 0.870 |
Why?
| | Adolescent Development | 2 | 2018 | 90 | 0.870 |
Why?
| | Saliva | 9 | 2015 | 251 | 0.760 |
Why?
| | Puberty | 2 | 2015 | 152 | 0.750 |
Why?
| | Hematopoietic Stem Cells | 1 | 2025 | 411 | 0.730 |
Why?
| | Repressor Proteins | 1 | 2025 | 430 | 0.730 |
Why?
| | Stress, Physiological | 1 | 2025 | 454 | 0.730 |
Why?
| | Interleukin-2 | 2 | 2020 | 456 | 0.700 |
Why?
| | Actigraphy | 6 | 2025 | 126 | 0.660 |
Why?
| | Single-Domain Antibodies | 1 | 2020 | 15 | 0.630 |
Why?
| | Photoperiod | 4 | 2017 | 53 | 0.630 |
Why?
| | Blood Glucose | 5 | 2017 | 2278 | 0.600 |
Why?
| | Adolescent | 23 | 2025 | 22130 | 0.590 |
Why?
| | Homeostasis | 4 | 2018 | 636 | 0.580 |
Why?
| | Time Factors | 15 | 2025 | 6966 | 0.570 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 369 | 0.560 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2020 | 2537 | 0.560 |
Why?
| | Sleep Wake Disorders | 5 | 2024 | 308 | 0.540 |
Why?
| | Sex Characteristics | 3 | 2017 | 792 | 0.500 |
Why?
| | Jet Lag Syndrome | 5 | 2022 | 13 | 0.470 |
Why?
| | Female | 41 | 2025 | 75943 | 0.450 |
Why?
| | Male | 37 | 2025 | 70179 | 0.430 |
Why?
| | Specimen Handling | 1 | 2015 | 182 | 0.430 |
Why?
| | Peptides | 1 | 2020 | 979 | 0.420 |
Why?
| | Models, Neurological | 1 | 2015 | 251 | 0.410 |
Why?
| | Humans | 55 | 2025 | 141754 | 0.410 |
Why?
| | Melanoma | 2 | 2020 | 792 | 0.410 |
Why?
| | Students | 3 | 2019 | 648 | 0.380 |
Why?
| | Sleep Stages | 1 | 2012 | 76 | 0.370 |
Why?
| | Adult | 27 | 2025 | 39391 | 0.360 |
Why?
| | Feeding and Eating Disorders | 1 | 2014 | 168 | 0.360 |
Why?
| | Occupational Health | 1 | 2014 | 208 | 0.360 |
Why?
| | Feeding Behavior | 2 | 2014 | 682 | 0.350 |
Why?
| | Depression | 4 | 2017 | 1508 | 0.320 |
Why?
| | Surveys and Questionnaires | 12 | 2024 | 5974 | 0.290 |
Why?
| | Aging | 2 | 2015 | 1924 | 0.280 |
Why?
| | Child Development | 1 | 2011 | 499 | 0.250 |
Why?
| | Cell Self Renewal | 1 | 2025 | 54 | 0.230 |
Why?
| | Body Weight | 2 | 2019 | 997 | 0.220 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2023 | 50 | 0.220 |
Why?
| | Darkness | 2 | 2005 | 27 | 0.220 |
Why?
| | Hematopoiesis | 1 | 2025 | 194 | 0.210 |
Why?
| | Phototherapy | 3 | 2013 | 46 | 0.210 |
Why?
| | Clothing | 1 | 2003 | 22 | 0.210 |
Why?
| | Arousal | 1 | 2004 | 160 | 0.210 |
Why?
| | Gadolinium | 1 | 2024 | 81 | 0.200 |
Why?
| | Sleep Initiation and Maintenance Disorders | 2 | 2024 | 192 | 0.200 |
Why?
| | Young Adult | 8 | 2021 | 13749 | 0.200 |
Why?
| | Mood Disorders | 1 | 2004 | 141 | 0.200 |
Why?
| | Time Management | 1 | 2023 | 21 | 0.200 |
Why?
| | Middle Aged | 13 | 2025 | 34647 | 0.190 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2022 | 47 | 0.190 |
Why?
| | Pediatric Obesity | 2 | 2019 | 601 | 0.180 |
Why?
| | NF-kappa B | 2 | 2023 | 692 | 0.180 |
Why?
| | Neoplasms | 3 | 2024 | 2747 | 0.180 |
Why?
| | Mice | 7 | 2025 | 18109 | 0.180 |
Why?
| | Child | 10 | 2024 | 22414 | 0.170 |
Why?
| | Li-Fraumeni Syndrome | 1 | 2020 | 14 | 0.170 |
Why?
| | Phagocytes | 1 | 2021 | 103 | 0.160 |
Why?
| | Cellular Reprogramming | 1 | 2021 | 99 | 0.160 |
Why?
| | Dermatitis, Atopic | 1 | 2024 | 331 | 0.160 |
Why?
| | Adie Syndrome | 1 | 2020 | 2 | 0.160 |
Why?
| | Camelids, New World | 1 | 2020 | 9 | 0.160 |
Why?
| | United States | 6 | 2025 | 15310 | 0.160 |
Why?
| | Vaccines, Subunit | 1 | 2020 | 50 | 0.160 |
Why?
| | Photic Stimulation | 2 | 2015 | 256 | 0.160 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2021 | 209 | 0.160 |
Why?
| | Peyer's Patches | 1 | 2019 | 7 | 0.150 |
Why?
| | Immunoglobulin Class Switching | 1 | 2019 | 21 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2025 | 671 | 0.150 |
Why?
| | Universities | 1 | 2022 | 454 | 0.150 |
Why?
| | Drug Synergism | 1 | 2020 | 375 | 0.150 |
Why?
| | Molecular Mimicry | 1 | 2019 | 42 | 0.150 |
Why?
| | Immunotherapy | 2 | 2021 | 646 | 0.150 |
Why?
| | Receptors, Interleukin-2 | 1 | 2019 | 66 | 0.150 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 117 | 0.150 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 515 | 0.150 |
Why?
| | Natural Killer T-Cells | 1 | 2019 | 67 | 0.150 |
Why?
| | Body Height | 1 | 2019 | 200 | 0.150 |
Why?
| | Jamaica | 3 | 2025 | 5 | 0.140 |
Why?
| | Cancer Vaccines | 1 | 2020 | 167 | 0.140 |
Why?
| | Interleukin-15 | 1 | 2019 | 101 | 0.140 |
Why?
| | Ghana | 3 | 2025 | 38 | 0.140 |
Why?
| | Immunoglobulin Fragments | 1 | 2018 | 12 | 0.140 |
Why?
| | Mice, Knockout | 1 | 2025 | 3071 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 3495 | 0.140 |
Why?
| | Nanoparticles | 1 | 2024 | 484 | 0.140 |
Why?
| | Drug Design | 1 | 2019 | 168 | 0.140 |
Why?
| | Immunoglobulin G | 2 | 2019 | 900 | 0.140 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2018 | 45 | 0.140 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 103 | 0.130 |
Why?
| | Weight Gain | 1 | 2021 | 539 | 0.130 |
Why?
| | South Africa | 3 | 2025 | 240 | 0.130 |
Why?
| | Diabetic Retinopathy | 1 | 2020 | 201 | 0.130 |
Why?
| | Shift Work Schedule | 1 | 2017 | 11 | 0.130 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 562 | 0.130 |
Why?
| | Antigens, Neoplasm | 1 | 2020 | 322 | 0.130 |
Why?
| | Human Migration | 1 | 2017 | 24 | 0.130 |
Why?
| | Autoantigens | 1 | 2020 | 426 | 0.130 |
Why?
| | Africa | 1 | 2017 | 119 | 0.130 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 907 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 529 | 0.130 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1363 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 349 | 0.120 |
Why?
| | Animals | 7 | 2025 | 37749 | 0.120 |
Why?
| | T-Lymphocytes | 2 | 2023 | 2007 | 0.120 |
Why?
| | Psychomotor Performance | 2 | 2012 | 329 | 0.120 |
Why?
| | Sleep-Wake Transition Disorders | 1 | 2015 | 4 | 0.120 |
Why?
| | Preoptic Area | 1 | 2015 | 8 | 0.120 |
Why?
| | Thailand | 1 | 2015 | 17 | 0.120 |
Why?
| | Body Mass Index | 5 | 2021 | 2385 | 0.120 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2015 | 19 | 0.120 |
Why?
| | Europe | 1 | 2017 | 411 | 0.120 |
Why?
| | Glycemic Index | 1 | 2015 | 26 | 0.120 |
Why?
| | Genetic Variation | 1 | 2020 | 1000 | 0.120 |
Why?
| | Sexual Maturation | 1 | 2015 | 55 | 0.120 |
Why?
| | Bacteria | 1 | 2021 | 881 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2023 | 890 | 0.110 |
Why?
| | Occupations | 1 | 2014 | 50 | 0.110 |
Why?
| | Child, Preschool | 4 | 2024 | 11512 | 0.110 |
Why?
| | Neural Inhibition | 1 | 2015 | 177 | 0.110 |
Why?
| | Aged | 6 | 2020 | 24746 | 0.110 |
Why?
| | Breakfast | 1 | 2013 | 20 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2020 | 918 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2021 | 730 | 0.100 |
Why?
| | Seychelles | 2 | 2025 | 2 | 0.100 |
Why?
| | Syndrome | 1 | 2014 | 378 | 0.100 |
Why?
| | Central Nervous System Depressants | 1 | 2013 | 89 | 0.100 |
Why?
| | Vitamin B 12 | 1 | 2013 | 125 | 0.100 |
Why?
| | Glucose Intolerance | 1 | 2014 | 147 | 0.100 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2938 | 0.100 |
Why?
| | Nerve Net | 1 | 2015 | 281 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1771 | 0.090 |
Why?
| | Psychotherapy | 1 | 2013 | 184 | 0.090 |
Why?
| | Eating | 1 | 2014 | 392 | 0.090 |
Why?
| | Depressive Disorder | 1 | 2014 | 395 | 0.080 |
Why?
| | Random Allocation | 1 | 2010 | 367 | 0.080 |
Why?
| | Cognition | 1 | 2017 | 1228 | 0.080 |
Why?
| | Age Factors | 2 | 2017 | 3294 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1768 | 0.070 |
Why?
| | Energy Intake | 3 | 2017 | 513 | 0.070 |
Why?
| | Self Report | 2 | 2024 | 861 | 0.070 |
Why?
| | Prevalence | 1 | 2014 | 2799 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1621 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5697 | 0.060 |
Why?
| | Aviation | 1 | 2005 | 8 | 0.060 |
Why?
| | Work | 1 | 2005 | 23 | 0.060 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2004 | 38 | 0.050 |
Why?
| | Body Temperature | 1 | 2004 | 224 | 0.050 |
Why?
| | Lighting | 1 | 2003 | 30 | 0.050 |
Why?
| | Memory Disorders | 1 | 2004 | 182 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2024 | 330 | 0.050 |
Why?
| | Rest | 1 | 2024 | 128 | 0.050 |
Why?
| | Signal Transduction | 3 | 2022 | 5169 | 0.050 |
Why?
| | Mental Recall | 1 | 2004 | 210 | 0.050 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2022 | 41 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2003 | 117 | 0.050 |
Why?
| | Immunity | 1 | 2023 | 140 | 0.050 |
Why?
| | Social Class | 1 | 2024 | 268 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2020 | 4212 | 0.050 |
Why?
| | Health Status | 1 | 2007 | 824 | 0.040 |
Why?
| | Depression, Postpartum | 1 | 2003 | 135 | 0.040 |
Why?
| | Fear | 1 | 2024 | 347 | 0.040 |
Why?
| | Germ Cells | 1 | 2020 | 64 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2004 | 518 | 0.040 |
Why?
| | Reflex, Pupillary | 1 | 2020 | 6 | 0.040 |
Why?
| | DNA Damage | 1 | 2022 | 429 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2004 | 1093 | 0.040 |
Why?
| | Time | 1 | 2019 | 87 | 0.040 |
Why?
| | Nuclear Transfer Techniques | 1 | 2019 | 3 | 0.040 |
Why?
| | Precision Medicine | 1 | 2024 | 434 | 0.040 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 8 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 14 | 0.040 |
Why?
| | Galactosylceramides | 1 | 2019 | 25 | 0.040 |
Why?
| | Meals | 1 | 2021 | 132 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 558 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5815 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 80 | 0.040 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 102 | 0.040 |
Why?
| | Epidemics | 1 | 2019 | 92 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 215 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 825 | 0.040 |
Why?
| | Protein Stability | 1 | 2019 | 175 | 0.040 |
Why?
| | Feces | 1 | 2021 | 505 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4421 | 0.030 |
Why?
| | Genetic Testing | 1 | 2020 | 463 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2021 | 792 | 0.030 |
Why?
| | Diet | 2 | 2017 | 1282 | 0.030 |
Why?
| | Hydrocortisone | 1 | 2020 | 318 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2019 | 485 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2022 | 859 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 246 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2021 | 647 | 0.030 |
Why?
| | Mothers | 1 | 2003 | 785 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 304 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2903 | 0.030 |
Why?
| | Binding Sites | 1 | 2019 | 1316 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2019 | 2158 | 0.030 |
Why?
| | Public Health | 1 | 2019 | 587 | 0.030 |
Why?
| | Computer Simulation | 1 | 2019 | 1015 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2576 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1604 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1562 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2902 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 2006 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7777 | 0.020 |
Why?
| | Linear Models | 1 | 2013 | 858 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2018 | 1474 | 0.020 |
Why?
| | Vaccination | 1 | 2019 | 1472 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5909 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 10482 | 0.010 |
Why?
| | MMPI | 1 | 2005 | 8 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 198 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2005 | 177 | 0.010 |
Why?
| | Personality | 1 | 2005 | 139 | 0.010 |
Why?
| | Insulin | 1 | 2013 | 2491 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7923 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 587 | 0.010 |
Why?
| | Pregnancy | 1 | 2003 | 7092 | 0.000 |
Why?
|
|
Crowley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|